Financebotresearch desk研究台

CNM › analyze

CNM · Analyze

ACCUMULATE Industrials

Price: $43.74 | 52wk range: $41.88–$67.18 | Mkt cap: $8.47B | Fwd P/E: 13.55x | No dividend

0. Knowledge Check

python .mcp/kb.py find CNM → no matches, nothing known. No live note or prior report exists on CNM. This is a first look — everything below is derived fresh. No coverage-map field (Themes/) has swept industrial distribution specifically, so nothing to cite there either.

Playbook pitfalls checked before trusting vendor numbers: - CNM is a US domestic issuer, not an ADR — the ADR share-count/currency traps (pitfall-adr-ticker-resolution, pitfall-currency-mixed-ev-is-invertible-on-adrs, pitfall-adr-book-value-corrupts-price-to-book) do not apply. - CNM is an active Up-C (pitfall-up-c-structure-corrupts-six-vendor-fields territory) — Core & Main, Inc. sits over Core & Main Holdings, LP, with a small remaining pool of Class B/exchangeable LP units from the pre-IPO CD&R/management structure. Checked the diagnostic: basic weighted-average shares (189.7M, roic.ai) reconciles closely to balance-sheet shares outstanding (188.8M), and the diluted add-on (~8.2M) is a normal RSU/option dilution, not a suspicious LP-unit double-count. Conclusion: the share-count and EPS fields survive the Up-C check, but fin.py's Insider% = 0.00 almost certainly understates true insider/management economic ownership (LP units held by execs are not "common stock" in the vendor's insider-ownership field) — treat that one field as unreliable, everything else as usable. - pattern-buyback-manufactured-eps-screens-as-growth — directly applicable, see §1.6. Diluted EPS growth (2.7% CAGR, 3yr) trails net-income growth (6.4% CAGR) because of NCI attribution, but more importantly operating income actually declined over the same window while EPS still rose — a real instance of buybacks (share count −7%/yr) doing more work than the underlying operating business. Flagged as a named risk in synthesis, not disqualifying. - pitfall-vendor-forward-eps-is-the-wrong-fiscal-year / pitfall-fin-py-snapshot-mixes-annual-and-mrq-dates — CNM's fiscal year ends Jan 31, so "FY2026" in vendor feeds and in this report means the year ended 2026-01-31, one calendar year behind the label most people would guess. Every figure below is dated by period-end, not by label, to avoid this trap.

1. Fundamentals

Core & Main is the largest pure-play specialty distributor of water, wastewater, storm drainage and fire-protection products in the US, built via a 2017–2021 CD&R-sponsored roll-up of ~90+ local/regional distributors, IPO'd July 2021. ~350+ branches, ~5,600 employees. CD&R fully exited its remaining stake in January 2024 (sold 19.8M shares at $41.50 — notably, below today's price 2.5 years later once inflation/EPS growth is set aside, i.e. the stock has round-tripped through that overhang).

1.1 Free Cash Flow (only 4 annual periods available — company IPO'd 2021, roic.ai free tier also

caps history at 2yr per pitfall-roicai-free-plan-caps-history-at-two-years, so an 8yr FCF CAGR is not obtainable; this is a data-availability limit, not a vendor error)

FY end (Jan 31) 2023 2024 2025 2026
OCF $401M $1,070M $621M $650M
Capex −$25M −$39M −$35M −$46M
FCF $376M $1,033M $586M $604M
FCF/share — — $3.24 $3.43 (roic.ai) / $3.05 (fin.py)*

*Small divergence between fin.py (uses diluted share count) and roic.ai (uses weighted-average basic) — both are legitimate, just different denominators; use the range $3.05–3.43.

3yr FCF CAGR (2023→2026) is nominally 17.1%, but FY2024's $1.03B FCF was inflated by a large working- capital release (PVC destocking); FY2025/FY2026 at $586–604M are the more representative run-rate. Capex is tiny — 0.6% of revenue. This is a capital-light distribution model: the moat (if any) is built from network density and working-capital financing for contractors, not fixed assets.

1.2 Capital allocation (FY2026, $604M FCF)

  • M&A (bolt-ons + Canada Waterworks): −$61M
  • Net debt paydown: −$117M (repaid $267M, issued $150M) — actively deleveraging this year
  • Buybacks: the balance, ~$425M (no dividend; FY2026 YTD-through-Q1 alone repurchased 7.5M shares for $349M per company disclosure)
  • No dividend. All capital return is via buyback.

Prior year (FY2025) leaned harder on debt: $1.72B issued (funded a $748M acquisition tranche plus buybacks), then FY2026 reversed that with net repayment — capital allocation discipline looks reasonable, not empire-building, and the deleveraging shows up in the credit ratios below.

1.3 Debt-to-Assets & credit quality

  • Debt/Assets: 40.0% (FY2026), down from 42.7% (FY2025)
  • Net debt/EBITDA: 2.11x (FY2026), down from 2.47x (FY2025) — the more meaningful leverage metric than the balance-sheet D/E ratio fin.py reports (115.94%), which looks alarming only because book equity is thin from years of buybacks against a goodwill-heavy balance sheet (see §3).
  • Interest coverage improving: EBITDA/Interest 7.6x (FY2026) vs 6.4x (FY2025); OpInc/Interest 6.0x vs 5.1x. Coverage is healthy and improving, not a leveraged-name concern.
  • $750M of senior notes priced at 6% (2034 maturity) to refinance/extend the term loan — a manageable, investment-grade-adjacent maturity profile for a company this size.

1.4 Shares outstanding trajectory

Diluted shares: 246.2M (2023) → 227.8M (2024) → 201.4M (2025) → 197.9M (2026) — −7.0% CAGR, a real and sustained buyback tailwind to per-share value. This is the single biggest driver of EPS growth (see §1.6) and is funded from FCF, not primarily from debt in the most recent year.

1.5 Top & bottom line growth

FY end (Jan 31) 2023 2024 2025 2026 CAGR (3yr)
Revenue $6.65B $6.70B $7.44B $7.65B 4.8%
Gross profit $1.79B $1.82B $1.98B $2.06B ~4.8% (margin flat)
Operating income $775M $740M $719M $722M −2.3% (declining)
Net income $366M $371M $411M $441M 6.4%
Diluted EPS $2.13 $2.15 $2.13 $2.31 2.7%

The revenue/gross-profit line and the operating-income line have diverged. Revenue and gross profit both grew ~4.8%/yr; operating income shrank over the same stretch. That gap is SG&A growing faster than gross profit — consistent with integration costs and greenfield-branch investment from an M&A-heavy growth strategy that has not yet matured into operating leverage (see §2.1 for the diagnostic that shows this is not yet resolved).

1.6 Per-share metrics & the buyback-EPS check

Revenue/share $38.65 (FY2026). FCF/share $3.05–3.43. Applying pattern-buyback-manufactured-eps-screens-as-growth's diagnostic — operating-income CAGR (−2.3%) vs EPS CAGR (+2.7%) — the entire positive EPS growth in this window is share-count-manufactured; the operating business, on this metric, did not grow at all. Net income did grow (6.4%), but faster than operating income because of falling interest expense and Up-C NCI mechanics, not organic operating improvement. This is a real, moderate instance of the pattern (not as extreme as the Gartner case in the Playbook note — CNM's buyback is FCF-funded, not >100%-of-FCF debt-funded — but the underlying message is the same: don't read the EPS line as evidence the business is compounding.

2. Moat

2.1 Quantitative base — ROIC and margins

ROIC (return on invested capital, roic.ai): 12.56% (FY2026), down from 13.79% (FY2025). Gross margin: 26.93% (FY2026) vs 26.61% (FY2025) — flat to slightly improving. Operating margin: 9.44% (FY2026) vs 9.66% (FY2025) — compressing, and compressing more over the 3-year window (11.65% in FY2023 → 9.44% in FY2026, ~220bp of erosion).

Applying the incremental-margin identity (pattern-incremental-margin-below-average-locks-in-decay, written for gross margin but the arithmetic is general): incremental gross margin FY2026 vs FY2025 = ΔGross profit / ΔRevenue = $80M / $210M = 38.1%, above the ~27% average — gross margin is healthy and should keep drifting up at the margin, consistent with the observed flat-to-rising trend. But incremental operating margin = ΔOpInc / ΔRevenue = $3M / $210M = 1.46% (matches roic.ai's own incremental_operating_margin field exactly), far below the 9.44% average operating margin. By the same identity: while the incremental sits this far below the average, the average operating margin must keep falling as revenue grows — this is arithmetic, not a forecast, and it is why operating margin has compressed every year since 2023 despite management's "disciplined execution" language. This is the single most important quantitative finding in this report — the moat is intact at the gross-margin line (pricing power, purchasing scale) but is being taxed away below it by the cost of the M&A/greenfield growth engine. Whether that engine eventually matures into leverage (bull case) or keeps compounding (bear case) is exactly the open question — decompose it next earnings print.

2.2 Adversarial stress-test

"You are a well-funded rival. How easily can you enter this market, sustain a threat, and disrupt the incumbent?" Moderately hard, not easy. Replicating CNM's 350+ branch density, contractor credit relationships, engineering/spec support for municipal buyers, and private-label sourcing would take years and real capital — but it is not technologically hard, and CNM itself is the proof: it was built via the same roll-up playbook by CD&R in four years (2017–2021). QXO (Brad Jacobs), already in the adjacent building-products distribution space via its 2025 Beacon Roofing acquisition and explicitly pursuing a "roll-up the fragmented distributor" strategy, is a concrete, named, well- funded threat that could target the same waterworks/fire-protection niche CNM occupies — this is not a hypothetical, it is the same financial-engineering playbook CNM's own history demonstrates works. Fastenal, Ferguson and SiteOne are existing scale peers in adjacent categories; none has committed capital to waterworks specifically yet, but the door is not locked.

2.3 Revenue-stream map

  • Municipal (water utilities, public works) — the majority of demand, non-discretionary (pipes break, utilities must replace them regardless of the economic cycle), durable, low disruption risk.
  • Residential/private construction (new-development lot infrastructure) — the cyclical piece, currently soft (sunbelt lot-development pullback cited on the Q1 FY26 call), tied to housing starts.
  • Fire protection / storm drainage — smaller, similar dynamics to core waterworks.

2.4 Disruption forecast

Near-term (0-3yr): PVC/ductile-iron pipe pricing cycle and residential volume are the swing factors — cyclical, not structural. 5-10yr: product-technology substitution risk is low (municipal specs are sticky, product cycles are long); the real structural risk is a capital-funded competitor roll-up (QXO-style) compressing CNM's relative scale advantage, and the margin-decay identity in §2.1 continuing if the M&A/greenfield engine doesn't mature.

2.5 Evergreen assessment

Water/wastewater infrastructure replacement is a genuinely forever category — pipes fail, codes tighten, municipal budgets for water infrastructure are one of the more durable line items in public spending. The company is evergreen at the demand level. The margin structure is not yet proven evergreen — see §2.1.

3. Valuation

Graham's Intrinsic Value is not meaningful here and should not be weighted — √(22.5 × EPS × BVPS) = √(22.5 × 2.38 × 10.86) ≈ $24.12, using headline EPS(ttm) and BVPS. But CNM carries $1.92B of goodwill against $2.00B of total equity — tangible book value per share is actually NEGATIVE (−$3.95, roic.ai), a direct consequence of the CD&R-era roll-up being financed with acquisition premiums now sitting as goodwill. Graham's model assumes real asset backing; there is none here beyond intangibles. Stating this explicitly rather than reporting a fake-precise $24 "intrinsic value" that would imply the stock is wildly overvalued on a metric that doesn't apply to this company type.

FCF-multiple approach (primary valuation lens for this name): FCF/share $3.05–3.43. A reasonable multiple range for a moderate-moat, mid-single-digit organic grower with a healthy and improving balance sheet is 12-16x FCF → implied fair value ≈ $42–55. Current price $43.74 sits at the low end of that band.

Bogle's Expected Return (no dividend, so pure earnings-growth + multiple-change): organic EPS growth (ex-buyback) is closer to low-single-digit given the §2.1 margin-decay finding and flat-to- modest revenue growth (FY2026 guide: 2-3%); buybacks historically added another ~5-7%/yr to EPS (moderating as the pace of repurchase slows with deleveraging priorities). Total EPS growth of roughly 6-9%/yr is a reasonable base case if the multiple holds — an 6-9% expected return with no yield cushion is adequate but not exceptional for the risk taken. Multiple re-rating (fwd P/E has compressed from a post-IPO band that ran high-teens-to-20s down to 13.55x today) would add meaningfully on top if growth stabilizes and margin-decay identity turns favorable — that is the optionality, not the base case.

DYT / DDM: not applicable — CNM pays no dividend.

Trim set as a forward multiple, not a fixed dollar, per house convention: 18x fwd — a meaningful re-rating back toward the upper end of its own post-IPO band, not a return to euphoric multiples. At the current implied forward EPS (~$3.23, from $43.74/13.55x), 18x fwd ≈ $58, which is usefully below the current $60.82 analyst-consensus target — conservative by design.

4. Sentiment — why is CNM near its 52-week low right now?

Primarily cyclical/macro, with one structural thread worth tracking.

  1. Soft FY2026 revenue guidance ($7.8-7.9B, implying only 2-3% growth) reaffirmed at Q1 FY26 (reported ~June 2026), below what analysts had modeled — the stock has been de-rating on decelerating-growth fear since. (Simply Wall St)
  2. PVC pipe price deflation remains a persistent year-over-year revenue headwind — management describes pricing as "stabilized sequentially" but still down YoY, and flags that further supplier price increases (or lack thereof) is the swing factor for H2. This is an input-cost cycle, not a company-specific failure — PVC pricing is set by resin capacity/demand across the whole distribution channel, not by CNM's execution. (Yahoo Finance Q2 outlook coverage)
  3. Residential end-market softness, concentrated in sunbelt lot development, is a housing-starts- cycle story, not a share-loss story — organic volumes were down ~1% YoY in Q1 FY26 with management describing conditions as "largely stabilized" since. Municipal demand (the majority of the mix) is holding up on non-discretionary, durably funded utility spending. (Q1 FY26 earnings call coverage)
  4. Repeated analyst price-target cuts through 2026 (Citigroup $54→$53, Goldman Sachs $68→$60, Truist $56→$50, Deutsche Bank $65→$62, Barclays $63→$62) — but the ratings themselves have mostly held at Buy/Overweight/Outperform. This reads as the Street trimming growth numbers, not abandoning the thesis — consensus target $60.82 still implies ~39% upside from spot. (TipRanks/analyst tracking)
  5. Insider activity is mixed and not a strong signal either way. A long, steady stream of executive stock sales through 2025-2026 ($40-65/share range) is visible — but this reads as normal post-lockup diversification from a PE-rollup management team (per pitfall-yahoo-insider-purchases-counts-rsu-grants, treat the "grants" noise separately from real sales). The one genuine signal in the other direction: Director James Hope has personally purchased shares twice in 2026 (1,972 shares at $50.70 in April; 2,067 shares at $46.01 in July) — small in size, but real open-market buying by an insider as the stock kept falling, which is at least a mild positive tell rather than a red flag.
  6. CD&R's sponsor overhang is fully gone (complete exit January 2024) — the stock is not sitting on a known future supply of insider shares the way a recently-IPO'd PE rollup often is.

Verdict on the "why": mostly sentiment/cyclical (decelerating growth optics + PVC price cycle + housing softness), not a broken business — but the §2.1 operating-margin-decay identity is a real, computable structural thread that the market may also be pricing, correctly, and that the Sentiment lens alone would miss.

5. Synthesis — weighted verdict

Company type: mature, non-dividend-paying, capital-light industrial distributor, moderate organic grower, buyback-funded capital return. Per the framework, for this profile Fundamentals + Valuation carry the most weight, with Moat providing the key tempering risk and Sentiment explaining the timing.

The case for "quality on sale": durable, non-discretionary end-market majority (municipal water infrastructure), disciplined and improving balance sheet (net debt/EBITDA down to 2.11x, actively deleveraging even while returning capital), capital-light model (0.6% capex/revenue), consistent FCF generation, no sponsor overhang, still-Buy-rated by the sell side, trading at the low end of its own post-IPO multiple band and at the low end of a defensible $42-55 FCF-based fair-value range.

The named tension: operating income has declined over the same 3-year window revenue grew 4.8%/yr, and the incremental-operating-margin identity says this compression is arithmetically locked in until the M&A/greenfield engine's marginal economics improve — that has not yet happened as of the FY2026 print. A meaningful share of the "quality" narrative rests on gross-margin stability and balance-sheet discipline, while the bottom-line growth investors actually see is manufactured more by the −7%/yr buyback than by the operating business (§1.6). This is not disqualifying — the buyback is FCF-funded, not debt-funded, and is a legitimate capital-allocation choice at this valuation — but it means the stock is not the double-lever "cheap AND compounding" setup a first read of the headline EPS suggests.

Weighing it: the market's de-rating (52wk-high-to-low: −35%) looks larger than the fundamental deterioration (a 220bp operating-margin move over three years, a soft-but-still-positive 2-3% revenue guide) — consistent with sentiment overshooting cyclical/macro fear. But the operating-margin identity means part of that de-rating is earned, not purely emotional. Net: worth owning, not worth loading up on.

Verdict: ACCUMULATE. Conviction 6.0/10 — genuine tension between a cheap, disciplined balance sheet and a real, unresolved operating-leverage problem below the gross-margin line; short public trading history (2021 IPO) also limits confidence in any long-run CAGR.

Entry zone: $40-46 (essentially the current price / 52-week-low band — already reasonable, no need to wait for a much lower print). Fair value: $42-55. Trim: 18x fwd (≈$58 at current forward EPS — a re-rating target, not a euphoria target). Recheck at the Q2 FY26 print, 2026-09-03 — the report that will show whether organic volume has stabilized, whether PVC pricing turned, and critically whether incremental operating margin has started closing the gap to the average (the single number that would most upgrade this thesis) or widened it further (which would downgrade it).

Key risks that would break this thesis: 1. Incremental operating margin stays depressed for another 2-3 quarters — confirms the M&A/ greenfield growth engine structurally dilutes returns rather than temporarily digesting them, and the moat argument weakens to "gross-margin pricing power only." 2. A well-funded consolidator (QXO or similar) enters waterworks distribution directly — CNM's own history proves the roll-up playbook is replicable with enough capital; this would compress both organic growth and acquisition-multiple economics simultaneously. 3. Housing-starts/residential softness deepening rather than stabilizing, on top of a PVC-pricing re-acceleration downward, would pressure the FY26 guide further and could trigger another leg of analyst target cuts even without a change in the long-run story.

Sources